Department of Physiology & Pharmacology, Des Moines University Osteopathic Medical Center, 3200 Grand Avenue, Des Moines, IA 50312, United States.
Department of Physiology & Pharmacology, Des Moines University Osteopathic Medical Center, 3200 Grand Avenue, Des Moines, IA 50312, United States.
Biochem Pharmacol. 2018 Jun;152:187-200. doi: 10.1016/j.bcp.2018.03.027. Epub 2018 Mar 30.
The angiotensin II receptor type 1 (ATR) mediates many Ca-dependent actions of angiotensin II (AngII). Calmodulin (CaM) is a key transducer of Ca signals in cells. Two locations on the receptor's submembrane domains (SMD) 3 and 4 are known to interact with CaM. However, the binding sites for CaM, biochemical properties of the interactions, and their functional impact are not fully understood. Using a FRET-based screening method, we identified a new binding site for CaM on SMD2 (a.a. 125-141), in addition to SMD3 and the juxtamembranous region of SMD4 (SMD4, a.a., 309-327). Simultaneous measurements of CaM binding and free Ca show that the interactions are Ca-dependent, with disparate K and EC50(Ca) values within the physiological range of cytoplasmic Ca. Full interaction between CaM and SMD3 requires the entire domain (a.a. 215-242) and has an EC50(Ca) value in the range of resting cytoplasmic Ca, suggesting ATR-CaM interaction can occur in resting conditions in cells. AngII induces robust ERK1/2 phosphorylation in primary vascular smooth muscle cells. This effect is suppressed by ATR inhibitor losartan and virtually abolished by CaM antagonist W-7. AngII-induced ERK1/2 phosphorylation is suppressed in cells expressing mutant ATR with reduced CaM binding at each identified binding domain. AngII triggers transient Ca signals in cells expressing wild-type ATR. These signals are reduced in cells expressing mutant ATR with reduced CaM binding at SMD3 or SMD4, but are very slow-rising, low amplitude signal in cells expressing ATR with reduced CaM binding at SMD2. The data indicate that CaM interactions with ATR can occur at various domains, with different affinities, at different physiological Ca levels, and are important for ATR-mediated signaling.
血管紧张素 II 受体 1 型(ATR)介导血管紧张素 II(AngII)的许多 Ca 依赖性作用。钙调蛋白(CaM)是细胞内 Ca 信号的关键转导蛋白。受体的亚膜域(SMD)3 和 4 上有两个已知的与 CaM 相互作用的位置。然而,CaM 的结合位点、相互作用的生化特性及其功能影响尚不完全清楚。我们使用基于 FRET 的筛选方法,除了 SMD3 和 SMD4 的跨膜区(SMD4,a.a.309-327)之外,还在 SMD2(a.a.125-141)上鉴定了 CaM 的新结合位点。同时测量 CaM 结合和游离 Ca 表明,相互作用是 Ca 依赖性的,在细胞质 Ca 的生理范围内具有不同的 K 和 EC50(Ca)值。CaM 与 SMD3 的完全相互作用需要整个结构域(a.a.215-242),并且具有处于静息细胞质 Ca 范围内的 EC50(Ca)值,这表明 ATR-CaM 相互作用可以在细胞的静息状态下发生。AngII 在原代血管平滑肌细胞中诱导强烈的 ERK1/2 磷酸化。该作用被 ATR 抑制剂 losartan 抑制,并用 CaM 拮抗剂 W-7 几乎消除。在每个鉴定的结合域中 CaM 结合减少的表达突变型 ATR 的细胞中,AngII 诱导的 ERK1/2 磷酸化被抑制。AngII 在表达野生型 ATR 的细胞中引发短暂的 Ca 信号。在 SMD3 或 SMD4 处 CaM 结合减少的表达突变型 ATR 的细胞中,这些信号减少,但在 CaM 结合减少的 SMD2 处表达 ATR 的细胞中,信号非常缓慢上升,幅度较低。数据表明,CaM 与 ATR 的相互作用可以在不同的域、不同的亲和力、不同的生理 Ca 水平下发生,并且对 ATR 介导的信号转导很重要。